|
|
|
|
|
|
- Tips on how to save for your child's education. |
|
|
|
- You can make more doing less. Here's how. |
|
|
|
- An American institution is in danger of fading away. |
|
|
|
- How to minimize risk while hanging on to the potential reward in small-cap investing. |
|
|
|
- The point man for attacks on the payday lending business still rings up profits. |
|
|
|
- LSI's deal for Agere was unexpected -- and not greeted warmly. |
|
|
|
- One Fool puts Big Goo's market cap in perspective. |
|
|
|
- It's all about the smart use of other people's money. |
|
|
|
- The company teams up with AstraZeneca to bring its antibiotic to worldwide markets. |
|
|
|
- Onyx shares fell on disappointing news, but there are other opportunities for the one-drug wonder. |
|
|
|
- Sirius finally makes a move to matter in video. |
|
|
|
- Attractive payments may have a catch. |
|
|
|
- Bargains or busts? Let's work together to find out. |
|
|
|
- What caused the biggest moves of the week? |
|
|
Stay Sharpe (Dec 09 2006 23:51 GMT) - Hope for performance, but prepare for risk. |
|
|
|
- What are they, and how do they work? |
|
|
|
- The November sales results for a few retailers raise some questions. |
|
|
|
- Somebody's been hitting the 57, because this stock is moving. |
|
|
|
- iVillage is now a TV star thanks to NBC Universal. |
|
|
|
- You can beat the market without breaking a sweat. No, really. |
|
|
|
- A peek at companies that overpromised and underdelivered. |
|
|
|
- Your yield may be just 2% when mine is a whopping 13%. Here's the secret. |
|
|
|
- What if other walks of life had restatements? |
|
|
|
- Companies whose business models have with too much in common with the airlines are likely to suffer a similar fate. |
|
|
|
- From the jumble of November sales data, inspiration emerges. |
|
|
|
- If price is important to you, you might be willing to wait to buy a stock. |
|
|
|
- If you want your money to grow, don't leave it in the 17th best place. |
|
|
|
- What you do with money accumulating in your checking account is important. |
|
|
|
- What is the impact of crude oil prices' recent rise? |
|
|
|
- Views you can use to get clues on tomorrow's news. |
|
|
|
- The search for 20% annualized returns starts now. |
|
|
|
- The company has been rebuffed in Australia as it tries to grow. |
|
|
|
- Could a new refining idea replace a dying synfuel business? |
|
|
|
- How you can profit from the potential of IPOs. |
|
|
|
- A Fool traces the evolution of the ETF market. |
|
|
|
- Beat the fund industry at its own game. |
|
|
|
- Cheesecake Factory is seeing some same-store weakness, but the long-term outlook is still strong. |
|
|
|
- How about a medieval business model that should never have survived into the 21st century? |
|
|
|
- Read this before you spend a penny on investment management. |
|
|
|
- A Foolish roundup of new-issue hits, misses, and no-shows. |
|
|
|
- A new feature allows users the chance to make the news. |
|
|
|
- Sales might be down, but the stocks are rising. |
|
|
|
- The country's leading retailer aims to make nice with its hires. |
|
|
|
- Sometimes it pays real money to pay attention to the complainers. |
|
|
|
- The upstart chipmaker is still on the right path. |
|
|
|
- Another episode in the great stock options saga. |
|
|
|
- Nintendo's Wii is a disruptive technology. Can Sony adapt? |
|
|
|
- More layoffs at Disney? It's not as bad as you think. |
|
|
|
- All the right ingredients for a leveraged buyout. |
|
|
|
- In addition to doing good, your donation can also nab you some tax benefits. |
|
|
|
- What now for the troubled automaker? |
|
|
|
- Baidu eyes Japan as its next growth market. |
|
|
|
- The marketing agency struggles with bad acquisitions and tough competitors. |
|
|
|
- Management leads a $4.7 billion buyout bid. Are other bids on the way? |
|
|
|
- Are investors overreacting in their negativity regarding bebe? |
|
|
|
- Don't overlook your small accounts -- they can add up, too. |
|
|
|
- Planning a June wedding? Consider March instead. |
|
|
|
- When more really isn't better. |
|
|
|
- The bigger they are, the harder they (might) fall. |
|
|
|
- Bad news follows the upbeat message delivered at Pfizer's R&D briefing. |
|
|
|
- Speculation on private newspaper buyouts goes further down the rabbit hole. |
|
|
|
- Lunch Q&A with the Great One. |
|
|
|
- Who's fallen hardest? Who can bounce highest? |
|
|
|
- This small pharma is quietly growing earnings. |
|
|
|
- Early indications of holiday sales last week showed strength, but investors seemed confused about whether to continue shopping on Wall Street. |
|
|
|
- Solid results from the first of three phase III trials cause Dynavax's shares to rise. |
|
|
|
- How much would you pay to get an advantage? |
|
